Cargando…

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials

Background: The translation of genomic discoveries to the clinic is the cornerstone of precision medicine. However, incorporating next generation sequencing (NGS) of hematologic malignancies into clinical management remains limited. Methods: We describe 235 patients who underwent integrated NGS prof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galanina, Natalie, Bejar, Rafael, Choi, Michael, Goodman, Aaron, Wieduwilt, Matthew, Mulroney, Carolyn, Kim, Lisa, Yeerna, Huwate, Tamayo, Pablo, Vergilio, Jo-Anne, Mughal, Tariq I., Miller, Vincent, Jamieson, Catriona, Kurzrock, Razelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356731/ https://www.ncbi.nlm.nih.gov/pubmed/30583461 http://dx.doi.org/10.3390/cancers11010011

Ejemplares similares

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
por: Pham, Timothy V., et al.
Publicado: (2020)

APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy
por: Boichard, Amélie, et al.
Publicado: (2018)

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer
por: Adashek, Jacob J., et al.
Publicado: (2019)

Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics
por: Cohen, Philip R., et al.
Publicado: (2016)

Portfolio of Dermochromes
por: Jamieson, W. Allan
Publicado: (1904)

Portfolio of Dermochromes
por: Jamieson, W. Allan
Publicado: (1903)

Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types
por: Schwaederle, Maria, et al.
Publicado: (2015)

Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples
por: Panda, Anshuman, et al.
Publicado: (2020)

Real‐World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim‐Chester Disease
por: Saunders, Ila M., et al.
Publicado: (2019)

Cover's universal portfolio, stochastic portfolio theory, and the numéraire portfolio
por: Cuchiero, Christa, et al.
Publicado: (2018)

Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
por: Kato, Shumei, et al.
Publicado: (2018)

Breakthrough project portfolio management: achieving the next level of capability and optimization
por: Kulathumani, Murali
Publicado: (2017)

Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers
por: Vu, Peter, et al.
Publicado: (2020)

Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies
por: Dimsdale, Joel E., et al.
Publicado: (2010)

Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing
por: Janku, Filip, et al.
Publicado: (2014)

Option Portfolio Selection with Generalized Entropic Portfolio Optimization
por: Mercurio, Peter Joseph, et al.
Publicado: (2020)

Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease
por: Cohen, Philip R., et al.
Publicado: (2017)

Schnitzler syndrome associated with MYD88 L265P mutation
por: Goodman, Aaron M., et al.
Publicado: (2019)

Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy
por: Cohen, Philip R, et al.
Publicado: (2020)

Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
por: Pham, Timothy V., et al.
Publicado: (2021)

Household portfolios /
Publicado: (2002)

The perfec portfolio
por: Brackman, Henrietta
Publicado: (1984)

Management of Portfolios
por: AXELOS
Publicado: (2011)

Portfolio Management
por: Stewart, Scott
Publicado: (2019)

Portfolio Management
por: Ginger Levin, PgMP, et al.
Publicado: (2014)

Portfolio Optimization
por: Best, Michael
Publicado: (2010)

The Editor's Portfolio
Publicado: (1850)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match
por: Subbiah, Vivek, et al.
Publicado: (2018)

Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
por: Agashe, Ruchi, et al.
Publicado: (2020)

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench
por: Subbiah, Vivek, et al.
Publicado: (2022)

Tumor mutational burden is not predictive of cytotoxic chemotherapy response
por: Nikanjam, Mina, et al.
Publicado: (2020)

Fuzzy Portfolio Selection Using Stochastic Correlation
por: Jo, Gumsong, et al.
Publicado: (2023)

Portfolio : case studies for business English /
por: Howe, Brian
Publicado: (1987)

Is the ESG portfolio less turbulent than a market benchmark portfolio?
por: Ouchen, Abdessamad
Publicado: (2021)

Early portfolio pruning: a scalable approach to hybrid portfolio selection
por: Gioia, Daniele G., et al.
Publicado: (2023)

Telomerase Reverse Transcriptase Promoter Alterations Across Cancer Types as Detected by Next-Generation Sequencing: A Clinical and Molecular Analysis of 423 Patients
por: Schwaederle, Maria, et al.
Publicado: (2017)

Molecular landscape of pancreatic cancer: implications for current clinical trials
por: Heestand, Gregory M., et al.
Publicado: (2015)

Click chemistry, 3D-printing, and omics: the future of drug development
por: Kurzrock, Razelle, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r3v2ea4s8d1c5pev12c43mq0a2